GlassScriptPhysician profile
Samir P Kanani
NPI 1558336719
$89,891.26
in general payments reported to CMS, 2019-2025
24 companies · $881 in 2025
The $881 reported for 2025 was more than what 82% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $17K · 2021: $13K · 2022: $19K · 2023: $17K · 2024: $4,993 · 2025: $881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $16K · Travel and Lodging: $4,324 · Food and Beverage: $2,349 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $16,050.00 |
| Travel and Lodging | $4,324.12 |
| Food and Beverage | $2,348.57 |
| Education | $104.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $86,940.06 | 2019-2024 | Optune |
| Boston Scientific Corporation | $608.98 | 2019-2025 | Spaceoar Vue System - 10ml |
| Palette Life Sciences, INC. | $528.41 | 2022-2023 | |
| Teleflex LLC | $288.89 | 2025 | Barrigel |
| Integra Lifesciences Corporation | $165.78 | 2023 | Duraseal Exact Spinal Sealant System, Codman Hakim, Codman Certas |
| Medtronic, INC. | $140.24 | 2025 | Osteocool Rf Ablation System |
| Gt Medical Technologies, INC | $138.70 | 2023 | Gammatile |
| Isoray, INC | $138.31 | 2023 | Brachytherapy Source |
| Myriad Genetic Laboratories, INC. | $124.74 | 2022 | |
| Novartis Pharmaceuticals Corporation | $107.92 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $102.04 | 2023 | Orgovyx |
| Merck Sharp & Dohme LLC | $92.04 | 2025 | Keytruda, Keytruda Qlex, Lynparza |
| Progenics Pharmaceuticals, INC. | $90.46 | 2022 | |
| Myovant Sciences INC. | $83.35 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $65.00 | 2025 | Libtayo |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmaessentia USA Corporation | $56.02 | 2025 | Besremi |
| Bioprotect Medical, INC. | $39.38 | 2024 | Bioprotect Balloon Implant System |
| Sirtex Medical INC | $36.56 | 2023 | Sir-Spheres Microspheres |
| Beone Medicines USA, INC. | $29.61 | 2025 | Brukinsa |
| Astellas Pharma US INC | $29.34 | 2025 | Padcev |
| Bayer Healthcare Pharmaceuticals INC. | $27.17 | 2025 | |
| Lilly USA, LLC | $23.00 | 2025 | Jaypirca, Verzenio |
| Takeda Pharmaceuticals U.S.A., INC. | $20.62 | 2025 | Fruzaqla |
| Angiodynamics, INC. | $14.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Kanani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.